Latest News and Archive
EACR is delighted to welcome QIAGEN as the newest Sustaining Member of EACR
EACR is delighted to welcome QIAGEN as the newest Sustaining Member of EACR.
In Sustaining Memberships, EACR forms partnerships with selected organisations who provide ongoing support for the work we do against cancer, helping the Association to grow and provide more for our members. For further information about QIAGEN please click here.
QIAGEN is the leading global provider of sample and assay technologies. They have developed and market more than 500 sample and assay products as well as automated solutions for such consumables. The company provides these products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer.